Mouse models for bacterial enteropathogen infections: insights into the role of colonization resistance

References

• The burden of foodborne diseases in the WHO European Region. (WHO Regional Office for Europe, Copenhagen, Denmark, 2017).
   Google Scholar
• CDC. Antibiotic resistance threats in the United States, 2019. (2019).
   Google Scholar
• Organization, W. H. World health statistics 2021: monitoring health for the SDGs, sustainable development goals. (WHO, 2021).
   Google Scholar
• ECDC), E. F. S. A. a. E. C. f. D. P. a. C. E. a. The European Union one health 2020 zoonoses report. EFSA Journal, doi:10.2903/j.efsa.2021.6971 (2021).
   Google Scholar
• Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014;14(667–685). doi:10.1038/nri3738.
   PubMedGoogle Scholar
• Torow N, Marsland BJ, Hornef MW, Gollwitzer ES. Neonatal mucosal immunology. Mucosal Immunol. 2017;10(5–17). doi:10.1038/mi.2016.81.
   PubMedGoogle Scholar
• Schirmer M, Smeekens, S. P., Vlamakis, H., Jaeger, M., Oosting, M., Franzosa, E. A. & Xavier, R. J. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell. 2016;167:1125–36. doi:10.1016/j.cell.2016.10.020.
   PubMed Web of Science ®Google Scholar
• Walter J, Ley R. The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol. 2011;65(411–429). doi:10.1146/annurev-micro-090110-102830.
   PubMedGoogle Scholar
• Rojas CA, Ramirez-Barahona S, Holekamp KE, Theis KR. Host phylogeny and host ecology structure the mammalian gut microbiota at different taxonomic scales. Anim Microbiome. 2021;3(33). doi:10.1186/s42523-021-00094-4.
   PubMedGoogle Scholar
• Nguyen TL, Vieira-Silva S, Liston A, Raes J. How informative is the mouse for human gut microbiota research? Dis Model Mech. 2015;8(1):1–16. doi:10.1242/dmm.017400.
   PubMed Web of Science ®Google Scholar
• Rajilic-Stojanovic M, Heilig HG, Tims S, Zoetendal EG, de Vos WM. Long-term monitoring of the human intestinal microbiota composition. Environ Microbiol. 2012. doi:10.1111/1462-2920.12023.
   PubMed Web of Science ®Google Scholar
• Kirk MD, Pires, S. M., Black, R. E., Caipo, M., Crump, J. A., Devleesschauwer, B. & Angulo, F. J. World health organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis. PLoS Med. 2015;12(e1001921). doi:10.1371/journal.pmed.1001921
   Google Scholar
• Havelaar AH, Kirk, MD, Torgerson, PR, Gibb, HJ, Hald, T, Lake, RJ, Praet, N, Bellinger, DC, de Silva, NR, Gargouri, N, Speybroeck, N, Cawthorne, A, Mathers, C, Stein, C, Angulo, FJ, Devleesschauwer, B. Vol. 12 (Public Library of Science 2015). doi:10.1371/journal.pmed.1001923.
   Google Scholar
• Abt MC, McKenney PT, Pamer EG. Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol. 2016;14(609–620). doi:10.1038/nrmicro.2016.108.
   PubMedGoogle Scholar
• Lim SC, Knight DR, Riley TV. Clostridium difficile and One health. Clin Microbiol Infect. 2020;26(857–863). doi:10.1016/j.cmi.2019.10.023.
   Google Scholar
• Furter M, Sellin ME, Hansson GC, Hardt WD. Mucus architecture and near-surface swimming affect distinct salmonella typhimurium infection patterns along the murine intestinal tract. Cell Rep. 2019;27:2665–2678. doi:10.1016/j.celrep.2019.04.106.
   PubMed Web of Science ®Google Scholar
• Ermund A, Schutte A, Johansson ME, Gustafsson JK, Hansson GC. Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer’s patches. Am J Physiol Gastrointest Liver Physiol. 2013;305:G341–347. doi:10.1152/ajpgi.00046.2013.
   PubMed Web of Science ®Google Scholar
• Roager HM, Hansen, L., Bahl, M. I., Frandsen, H. L., Carvalho, V., Gøbel, R. J. & Licht, T. R. Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. Nat Microbiol. 2016;1(16093). doi:10.1038/nmicrobiol.2016.93
   PubMedGoogle Scholar
• Arnoldini M, Cremer J, Hwa T. Bacterial growth, flow, and mixing shape human gut microbiota density and composition. Gut Microbes. 2018;9(559–566). doi:10.1080/19490976.2018.1448741.
   PubMedGoogle Scholar
• Han S, Lu, Y., Xie, J., Fei, Y., Zheng, G., Wang, Z. & Li, L. Probiotic gastrointestinal transit and colonization after oral administration: a long journey. Front Cell Infect Microbiol. 2021;11(609722). doi:10.3389/fcimb.2021.609722
   Google Scholar
• Takiishi T, Fenero CIM, Camara NOS. Intestinal barrier and gut microbiota: shaping our immune responses throughout life. Tissue Barriers. 2017;5(e1373208). doi:10.1080/21688370.2017.1373208.
   PubMedGoogle Scholar
• Ducarmon QR, Zwittink, R. D., Hornung, B. V. H., Van Schaik, W., Young, V. B., & Kuijper, E. J. Gut microbiota and colonization resistance against bacterial enteric infection. Microbiol Mol Biol Rev. 2019;83. doi:10.1128/MMBR.00007-19.
   PubMed Web of Science ®Google Scholar
• Kreuzer M, Hardt WD. How Food affects colonization resistance against enteropathogenic bacteria. Annu Rev Microbiol. 2020;74(787–813). doi:10.1146/annurev-micro-020420-013457.
   PubMedGoogle Scholar
• Stecher B, Berry D, Loy A. Colonization resistance and microbial ecophysiology: using gnotobiotic mouse models and single-cell technology to explore the intestinal jungle. FEMS Microbiology Reviews. 2013. doi:10.1111/1574-6976.12024.
   PubMed Web of Science ®Google Scholar
• Chen C, Yang X, Shen X. Confirmed and potential roles of bacterial t6SSS in the intestinal ecosystem. Front Microbiol. 2019;10(1484). doi:10.3389/fmicb.2019.01484.
   Google Scholar
• Heilbronner S, Krismer B, Brotz-Oesterhelt H, Peschel A. The microbiome-shaping roles of bacteriocins. Nat Rev Microbiol. 2021;19(726–739). doi:10.1038/s41579-021-00569-w.
   PubMedGoogle Scholar
• Rogers AWL, Tsolis RM, Baumler AJ. Salmonella versus the Microbiome. Microbiol Mol Biol Rev. 2021:85. doi:10.1128/MMBR.00027-19.
   PubMed Web of Science ®Google Scholar
• Nguyen BD, Cuenca, M., Hartl, J., Gül, E., Bauer, R., Meile, S. & Hardt, W. D. Import of aspartate and malate by DcuABC drives H2/fumarate respiration to promote initial salmonella gut-lumen colonization in mice. Cell Host Microbe. 2020;27:922–936. doi:10.1016/j.chom.2020.04.013.
   PubMed Web of Science ®Google Scholar
• Celis AI, Relman DA. Competitors versus collaborators: micronutrient processing by pathogenic and commensal human-associated gut bacteria. Mol Cell. 2020;78(570–576). doi:10.1016/j.molcel.2020.03.032.
   PubMedGoogle Scholar
• Liou MJ, Miller, B. M., Litvak, Y., Nguyen, H., Natwick, D. E., Savage, H. P. & Bäumler, A. J. Host cells subdivide nutrient niches into discrete biogeographical microhabitats for gut microbes. Cell Host Microbe. 2022;30:836–847. doi:10.1016/j.chom.2022.04.012.
   PubMed Web of Science ®Google Scholar
• Wittebole X, De Roock S, Opal SM. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence. 2014;5(226–235). doi:10.4161/viru.25991.
   PubMedGoogle Scholar
• Shkoporov AN, Clooney, A. G., Sutton, T. D., Ryan, F. J., Daly, K. M., Nolan, J. A. & Hill, C. The human gut virome is highly diverse, stable, and individual specific. Cell Host Microbe. 2019;26:527–541. doi:10.1016/j.chom.2019.09.009.
   PubMed Web of Science ®Google Scholar
• Zhou A, Yuan, Y., Yang, M., Huang, Y., Li, X., Li, S. & Tang, B. Crosstalk Between the gut microbiota and epithelial cells under physiological and infectious conditions. Frontiers in Cellular and Infection Microbiology. 2022;12:832672. doi:10.3389/fcimb.2022.832672 .
   PubMed Web of Science ®Google Scholar
• Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014;14(141–153). doi:10.1038/nri3608.
   PubMedGoogle Scholar
• Maier L, et al. Granulocytes impose a tight bottleneck upon the gut luminal pathogen population during Salmonella typhimurium colitis. PLoS Pathog. 2014;10(e1004557). doi:10.1371/journal.ppat.1004557
   Google Scholar
• Kaiser P, Diard M, Stecher B, Hardt W-D. The streptomycin mouse model for Salmonella diarrhea: functional analysis of the microbiota, the pathogen’s virulence factors, and the host’s mucosal immune response. Immunological Reviews. 2012;245:56–83. doi:10.1111/j.1600-065X.2011.01070.x.
   PubMed Web of Science ®Google Scholar
• Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu Rev Immunol. 2012;30(459–489). doi:10.1146/annurev-immunol-020711-074942.
   PubMedGoogle Scholar
• Molloy MJ, Bouladoux, N., Hand, T. W., Koo, L. Y., Naik, S. & Belkaid, Y. Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe. 2013;14(318–328). doi:10.1016/j.chom.2013.08.003
   PubMedGoogle Scholar
• Moor K, Diard, M., Sellin, M. E., Felmy, B., Wotzka, S. Y., Toska, A. & Slack, E. High-avidity IgA protects the intestine by enchaining growing bacteria. Nature. 2017;544(498–502). doi:10.1038/nature22058
   PubMedGoogle Scholar
• Mantis NJ, Rol N, Secretory Iga’s CB. complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 2011;4(603–611). doi:10.1038/mi.2011.41.
   Google Scholar
• Pike CM, Theriot CM. Mechanisms of colonization resistance against clostridioides difficile. The Journal of Infectious Diseases. 2020;223:S194–S200. doi:10.1093/infdis/jiaa408.
   Web of Science ®Google Scholar
• Mizrahi A, Bruxelle JF, Pechine S, Le Monnier A. Prospective evaluation of the adaptive immune response to SlpA in Clostridium difficile infection. Anaerobe. 2018;54(164–168). doi:10.1016/j.anaerobe.2018.09.008.
   PubMedGoogle Scholar
• Nagao-Kitamoto H, Nagao-Kitamoto, H., Leslie, J. L., Kitamoto, S., Jin, C., Thomsson, K. A., Gillilland III, M. G. & Kamada, N. Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota. Nat Med. 2020;26(608–617). doi:10.1038/s41591-020-0764-0
   PubMedGoogle Scholar
• Wotzka SY, Kreuzer, M., Maier, L., Arnoldini, M., Nguyen, B. D., Brachmann, A. O. & Hardt, W. D. Escherichia coli limits Salmonella Typhimurium infections after diet shifts and fat-mediated microbiota perturbation in mice. Nat Microbiol. 2019. doi:10.1038/s41564-019-0568-5.
   PubMed Web of Science ®Google Scholar
• Bohnhoff M, Drake BL, Miller CP. Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proc Soc Exp Biol Med. 1954;86(132–137). doi:10.3181/00379727-86-21030.
   PubMedGoogle Scholar
• Hugenholtz F, de Vos WM. Mouse models for human intestinal microbiota research: a critical evaluation. Cell Mol Life Sci. 2018;75(149–160). doi:10.1007/s00018-017-2693-8.
   PubMedGoogle Scholar
• Besser JM. Salmonella epidemiology: a whirlwind of change. Food Microbiol. 2018;71(55–59). doi:10.1016/j.fm.2017.08.018.
   PubMedGoogle Scholar
• Chai SJ, Gu W, O’Connor KA, Richardson LC, Tauxe RV. Incubation periods of enteric illnesses in foodborne outbreaks, United States, 1998-2013. Epidemiol Infect. 2019;147(e285). doi:10.1017/S0950268819001651.
   PubMedGoogle Scholar
• Axelrad JE, Olén, O., Askling, J., Lebwohl, B., Khalili, H., Sachs, M. C., & Ludvigsson, J. F. Gastrointestinal infection increases odds of inflammatory bowel disease in a nationwide case-control study. Clin Gastroenterol Hepatol. 2019;17:1311–1322. doi:10.1016/j.cgh.2018.09.034.
   PubMed Web of Science ®Google Scholar
• Doorduyn Y, Van Den Brandhof WE, Van Duynhoven YT, Wannet WJ, Van Pelt W. Risk factors for Salmonella Enteritidis and Typhimurium (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infections. Epidemiol Infect. 2006;134(617–626). doi:10.1017/S0950268805005406.
   PubMedGoogle Scholar
• Pavia AT, Shipman, L. D., Wells, J. G., Puhr, N. D., Smith, J. D., McKinley, T. W., & Tauxe, R. V. Epidemiologic evidence that prior antimicrobial exposure decreases resistance to infection by antimicrobial-sensitive Salmonella. J Infect Dis. 1990;161(255–260). doi:10.1093/infdis/161.2.255
   PubMedGoogle Scholar
• Barthel M, Hapfelmeier, S., Quintanilla-Martínez, L., Kremer, M., Rohde, M., Hogardt, M. & Hardt, W. D. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun. 2003;71 2839–2858).
   PubMed Web of Science ®Google Scholar
• Bakkeren E, Gül, E., Huisman, J. S., Steiger, Y., Rocker, A., Hardt, W. D., & Diard, M. Impact of horizontal gene transfer on emergence and stability of cooperative virulence in Salmonella Typhimurium. Nat Commun. 2022;13(1939). doi:10.1038/s41467-022-29597-7
   PubMedGoogle Scholar
• Bakkeren E, Huisman, J. S., Fattinger, S. A., Hausmann, A., Furter, M., Egli, A. & Hardt, W. D. Salmonella persisters promote the spread of antibiotic resistance plasmids in the gut. Nature. 2019;573(276–280). doi:10.1038/s41586-019-1521-8
   PubMedGoogle Scholar
• Bakkeren E, Diard M, Hardt W-D-D. Evolutionary causes and consequences of bacterial antibiotic persistence. Nature Reviews. Microbiology. 2020;18:479–490. doi:10.1038/s41579-020-0378-z.
   PubMed Web of Science ®Google Scholar
• Stecher B, Robbiani, R., Walker, A. W., Westendorf, A. M., Barthel, M., Kremer, M. & Hardt, W. D. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 2007;5:2177–2189. doi:10.1371/journal.pbio.0050244.
   PubMed Web of Science ®Google Scholar
• Stecher B, Paesold, G., Barthel, M., Kremer, M., Jantsch, J., Stallmach, T. & Hardt, W. D. Chronic Salmonella enterica serovar Typhimurium-induced colitis and cholangitis in streptomycin-pretreated Nramp1+/+ mice. Infect Immun. 2006;74(5047–5057). doi:10.1128/IAI.00072-06
   PubMedGoogle Scholar
• Stecher B, Chaffron, S., Käppeli, R., Hapfelmeier, S., Freedrich, S., Weber, T. C. & Hardt, W. D. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog. 2010;6(e1000711). doi:10.1371/journal.ppat.1000711
   Google Scholar
• Maier L, Vyas, R., Cordova, C. D., Lindsay, H., Schmidt, T. S. B., Brugiroux, S. & Hardt, W. D. Microbiota-derived hydrogen fuels Salmonella typhimurium invasion of the gut ecosystem. Cell Host Microbe. 2013;14(641–651). doi:10.1016/j.chom.2013.11.002
   PubMedGoogle Scholar
• Brugiroux S, Beutler, M., Pfann, C., Garzetti, D., Ruscheweyh, H. J., Ring, D. & Stecher, B. Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium. Nat Microbiol. 2016;2(16215). doi:10.1038/nmicrobiol.2016.215
   PubMedGoogle Scholar
• Garzetti D, Brugiroux, S., Bunk, B., Pukall, R., McCoy, K. D., Macpherson, A. J., & Stecher, B. High-quality whole-genome sequences of the oligo-mouse-microbiota bacterial community. Genome Announc. 2017;5. doi:10.1128/genomeA.00758-17.
   PubMedGoogle Scholar
• Stecher B, Macpherson, A. J., Hapfelmeier, S., Kremer, M., Stallmach, T., & Hardt, W. D. Comparison of Salmonella enterica serovar Typhimurium colitis in germfree mice and mice pretreated with streptomycin. Infect Immun. 2005;73(3228–3241). doi:10.1128/IAI.73.6.3228-3241.2005
   PubMedGoogle Scholar
• Chung H, Pamp, S. J., Hill, J. A., Surana, N. K., Edelman, S. M., Troy, E. B. & Kasper, D. L. Gut immune maturation depends on colonization with a host-specific microbiota. Cell. 2012;149(1578–1593). doi:10.1016/j.cell.2012.04.037
   PubMedGoogle Scholar
• Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 2004;4(478–485). doi:10.1038/nri1373.
   PubMedGoogle Scholar
• Smith K, McCoy KD, Macpherson AJ. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol. 2007;19(59–69). doi:10.1016/j.smim.2006.10.002.
   PubMedGoogle Scholar
• Yoo W, Zieba, J. K., Foegeding, N. J., Torres, T. P., Shelton, C. D., Shealy, N. G. & Byndloss, M. X. High-fat diet-induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide. Science. 2021;373(813–818). doi:10.1126/science.aba3683
   PubMedGoogle Scholar
• Lee JY, Cevallos, S. A., Byndloss, M. X., Tiffany, C. R., Olsan, E. E., Butler, B. P. & Bäumler, A. J. High-fat diet and antibiotics cooperatively impair mitochondrial bioenergetics to trigger dysbiosis that exacerbates pre-inflammatory bowel disease. Cell Host Microbe. 2020;28:273–284. doi:10.1016/j.chom.2020.06.001.
   PubMed Web of Science ®Google Scholar
• Zhang K, Riba, A, Nietschke, M, Torow, N, Repnik, U, Pütz, A. Minimal SPI1-T3SS effector requirement for Salmonella enterocyte invasion and intracellular proliferation in vivo. PLoS Pathog. 2018;14:e1006925. doi:10.1371/journal.ppat.1006925.
   PubMed Web of Science ®Google Scholar
• Relman D ( Anand Jagatia ed) ( Nature Portfolio, 2019).
   Google Scholar
• Maier L, Barthel, M, Stecher, B, Maier, RJ, Gunn, JS, et al. Salmonella Typhimurium strain ATCC14028 requires H2-hydrogenases for growth in the gut, but not at systemic sites. PLoS One. 2014;9(e110187). doi:10.1371/journal.pone.0110187
   Google Scholar
• Stecher B, Barthel, M, Schlumberger, MC, Haberli, L, Rabsch, W, Kremer, M, Hardt, WD, et al. Motility allows S. Typhimurium to benefit from the mucosal defence. Cell Microbiol. 2008;10:1166–1180. doi:10.1111/j.1462-5822.2008.01118.x.
   PubMed Web of Science ®Google Scholar
• Stecher B, Hapfelmeier, S, Muller, C, Kremer, M, Stallmach, T, Hardt, WD, et al. Flagella and chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis in streptomycin-pretreated mice. Infect Immun. 2004;72(7):4138–50. doi:10.1128/IAI.72.7.4138-4150.2004
   PubMed Web of Science ®Google Scholar
• Hapfelmeier S, Ehrbar, K, Stecher, B, Barthel, M, Kremer, M, Hardt, WD, et al. Role of the Salmonella pathogenicity Island 1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella enterica subspecies 1 serovar Typhimurium colitis in streptomycin-pretreated mice. Infect Immun. 2004;72:795–809.
   PubMed Web of Science ®Google Scholar
• Hapfelmeier S, Stecher, B, Barthel, M, Kremer, M, Müller, AJ, Heikenwalder, M, Stallmach, T, Hensel, M, Pfeffer, K, Akira, S, Hardt, WD, et al. The Salmonella pathogenicity Island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J Immunol. 2005;174:16–1685.
   Google Scholar
• Fattinger SA, Bock, D, Di Martino, ML, Deuring, S, Ventayol, PS, Ek, V, et al. Salmonella Typhimurium discreet-invasion of the murine gut absorptive epithelium. PLoS Pathog. 2020;16(e1008503). doi:10.1371/journal.ppat.1008503
   PubMedGoogle Scholar
• Müller AJ, Kaiser, P, Dittmar, KE, Weber, TC, Haueter, S, Endt, K, et al. Salmonella gut invasion involves TTSS-2-dependent epithelial traversal, basolateral exit, and uptake by epithelium-sampling lamina propria phagocytes. Cell Host & Microbe. 2012;11(1):19–32.
   PubMed Web of Science ®Google Scholar
• Hausmann A, Felmy, B, Kunz, L, Kroon, S, Berthold, DL, Ganz, G, et al. Intercrypt sentinel macrophages tune antibacterial NF-kappaB responses in gut epithelial cells via TNF. J Exp Med. 2021;218:11. doi:10.1084/jem.20210862.
   PubMed Web of Science ®Google Scholar
• Litvak Y, Mon, KKZ, Nguyen, H, Chanthavixay, G, Liou, M, Velazquez, EM. Commensal Enterobacteriaceae protect against salmonella colonization through oxygen competition. Cell Host Microbe. 2019;25(1):128–139. doi:10.1016/j.chom.2018.12.003.
   PubMed Web of Science ®Google Scholar
• Rivera-Chavez F, Zhang, LF, Faber, F, Lopez, CA, Byndloss, MX, Olsan, EE, et al. Depletion of butyrate-producing clostridia from the gut microbiota drives an aerobic luminal expansion of salmonella. Cell Host Microbe. 2016;19(4):443–454. doi:10.1016/j.chom.2016.03.004
   PubMed Web of Science ®Google Scholar
• Winter SE, Thiennimitr, P, Winter, MG, Butler, BP, Huseby, DL, Crawford, RW. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010;467(7314):426–429.
   PubMed Web of Science ®Google Scholar
• Rivera-Chavez F, Lopez, CA, Zhang, LF, Cracia-Pastor, L, Chavez-Arroyo, A, Lokken, KL, Tsolis, RM, Winter, S, Bäumler, AJ, et al. Energy taxis toward host-derived nitrate supports a salmonella pathogenicity island 1-independent mechanism of invasion. mBio. 2016;7:4. doi:10.1128/mBio.00960-16.
   PubMed Web of Science ®Google Scholar
• Zaharik ML, Vallance BA, Puente JL, Gros P, Finlay BB. Host-pathogen interactions: host resistance factor Nramp1 up-regulates the expression of Salmonella pathogenicity Island-2 virulence genes. Proc Natl Acad Sci U S A. 2002;99(15705–15710). doi:10.1073/pnas.252415599.
   PubMedGoogle Scholar
• Govoni G, Macrophage GP. NRAMP1 and its role in resistance to microbial infections. Inflamm Res. 1998;47(277–284). doi:10.1007/s000110050330.
   PubMedGoogle Scholar
• Sellin ME, Muller, AA, Felmy, B, Dolowschiak, T, Diard, M, Tardivel, A, et al. Epithelium-intrinsic NAIP/NLRC4 inflammasome drives infected enterocyte expulsion to restrict Salmonella replication in the intestinal mucosa. Cell Host Microbe. 2014;16(2):237–248. doi:10.1016/j.chom.2014.07.001
   PubMed Web of Science ®Google Scholar
• Fattinger SA, Geiser, P, Samperio Ventayol, P, Di Martino, ML, Furter, M, Felmy, B, et al. Epithelium-autonomous NAIP/NLRC4 prevents TNF-driven inflammatory destruction of the gut epithelial barrier in Salmonella-infected mice. Mucosal Immunol. 2021;14(3):615–629. doi:10.1038/s41385-021-00381-y
   PubMed Web of Science ®Google Scholar
• Fattinger SA, Sellin ME, Hardt WD Vol. 59 86‐94 (Elsevier Ltd, 2021).
   Google Scholar
• Hausmann A, Bock, D, Geiser, P, Berthold, DL, Fattinger, SA, Furter, M. Intestinal epithelial NAIP/NLRC4 restricts systemic dissemination of the adapted pathogen Salmonella Typhimurium due to site-specific bacterial PAMP expression. Mucosal Immunology. 2020;13(3)530–544. doi:10.1038/s41385-019-0247-0.
   PubMed Web of Science ®Google Scholar
• Hausmann A, Russo, G, Grossmann, J, Zünd, M, Schwank, G, Aebersold, R, et al. Germ-free and microbiota-associated mice yield small intestinal epithelial organoids with equivalent and robust transcriptome/proteome expression phenotypes. Cellular Microbiology. 2020;22(6):e13191. doi:10.1111/cmi.13191
   PubMed Web of Science ®Google Scholar
• Müller AA, Dolowschiak, T, Sellin, ME, Felmy, B, Verbree, C, Gadient, S, et al. An NK cell perforin response elicited via IL-18 controls mucosal inflammation kinetics during Salmonella gut infection. PLoS Pathogens. 2016;12(6):e1005723.
   PubMed Web of Science ®Google Scholar
• Songhet P, Barthel, M, Stecher, B, Müller, AJ, Kremer, M, Hansson, GC, et al. Stromal IFN-γR-signaling modulates goblet cell function during Salmonella Typhimurium infection. PloS one. 2011;6(7):e22459.
   PubMed Web of Science ®Google Scholar
• Agbor TA, Demma, Z, Mrsny, RJ, Castillo, A, Boll, EJ, McCormick, BA, et al. The oxido-reductase enzyme glutathione peroxidase 4 (GPX4) governs Salmonella Typhimurium-induced neutrophil transepithelial migration. Cell Microbiol. 2014;16(9):1339–1353. doi:10.1111/cmi.12290
   PubMed Web of Science ®Google Scholar
• Loetscher Y, Wieser, A, Lengefeld, J, Kaiser, P, Schubert, S, Heikenwalder, M, et al. Salmonella transiently reside in luminal neutrophils in the inflamed gut. PLoS One. 2012;7(4):e34812. doi:10.1371/journal.pone.0034812
   PubMed Web of Science ®Google Scholar
• Endt K, Stecher, B, Chaffron, S, Slack, E, Tchitchek, N, Benecke, A, et al. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal salmonella diarrhea. PLoS Pathogens. 2010;6:9. doi:10.1371/journal.ppat.1001097.
   PubMed Web of Science ®Google Scholar
• Diard M, Bakkeren, E, Lentsch, V, Rocker, A, Bekele, NA, Hoces, D, et al. A rationally designed oral vaccine induces immunoglobulin A in the murine gut that directs the evolution of attenuated Salmonella variants. Nat Microbiol. 2021;6(7):830–841. doi:10.1038/s41564-021-00911-1
   PubMed Web of Science ®Google Scholar
• Salazar-Gonzalez RM, McSorley SJ. Salmonella flagellin, a microbial target of the innate and adaptive immune system. Immunol Lett. 2005;101:117–122. doi:10.1016/j.imlet.2005.05.004.
   PubMed Web of Science ®Google Scholar
• Sztein MB. Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans. Clin Infect Dis. 2007;45(Suppl 1):S15–19. doi:10.1086/518140.
   PubMed Web of Science ®Google Scholar
• Murphy JR, Baqar, S, Munoz, C, Schlesinger, L, Ferreccio, C, Lindberg, AA, et al. Characteristics of humoral and cellular immunity to Salmonella typhi in residents of typhoid-endemic and typhoid-free regions. J Infect Dis. 1987;156(6):1005–1009. doi:10.1093/infdis/156.6.1005
   PubMed Web of Science ®Google Scholar
• Jacobson A, Lam L, Rajendram M, Tamburini F, Honeycutt J, Pham T, Van Treuren W, Pruss K, Stabler SR, Lugo K, et al. A gut commensal-produced metabolite mediates colonization resistance to salmonella infection. Cell Host Microbe. 2018;24(2):296–307. doi:10.1016/j.chom.2018.07.002.
   PubMed Web of Science ®Google Scholar
• Stecher B, Denzler, R, Maier, L, Bernet, F, Sanders, MJ, Pickard, DJ, et al. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae PNAS. 2012; 109(4):1269–1274. doi:10.1073/pnas.1113246109.
   PubMed Web of Science ®Google Scholar
• Velazquez EM, Nguyen, H, Heasley, KT, Seachao, CH, Gil, LM, Rogers, AWL, et al. Endogenous Enterobacteriaceae underlie variation in susceptibility to Salmonella infection. Nat Microbiol. 2019;4:1057–1064. doi:10.1038/s41564-019-0407-8.
   PubMed Web of Science ®Google Scholar
• Palmer JD, Mortzfeld, BM, Piattelli, E, Silby, MW, McCormick, BA, Bucci, V, et al. Microcin H47: a class IIb microcin with potent activity against multidrug resistant enterobacteriaceae. ACS Infect Dis. 2020;6(4):672–679. doi:10.1021/acsinfecdis.9b00302
   PubMed Web of Science ®Google Scholar
• Sassone-Corsi M, Nuccio, SP, Liu, H, Hernandez, D, Vu, CT, Takahashi, AA, et al. Microcins mediate competition among Enterobacteriaceae in the inflamed gut. Nature. 2016;540(7632): 280–283. doi:10.1038/nature20557
   PubMed Web of Science ®Google Scholar
• WHO. Campylobacter, https://www.who.int/news-room/fact-sheets/detail/campylobacter Accessed 4 November 2022. (2020).
   Google Scholar
• Bereswill S, Fischer, A, Plickert, R, Haag, LM, Otto, B, Kühl, AA, Dasti, JI, et al. Novel murine infection models provide deep insights into the “menage a trois” of Campylobacter jejuni, microbiota and host innate immunity. PLoS One. 2011;6:e20953. doi:10.1371/journal.pone.0020953.
   PubMed Web of Science ®Google Scholar
• Heimesaat MM, Backert S, Alter T, Human Campylobacteriosis-A BS. Serious Infectious threat in a one health perspective. Curr Top Microbiol Immunol. 2021;431:51–23. doi:10.1007/978-3-030-65481-8_1.
   Web of Science ®Google Scholar
• Kaakoush NO, Castano-Rodriguez N, Mitchell HM, Man SM. Global epidemiology of campylobacter infection. Clin Microbiol Rev. 2015;28(687–720). doi:10.1128/CMR.00006-15.
   PubMedGoogle Scholar
• Peterson MC. Clinical aspects of Campylobacter jejuni infections in adults. West J Med. 1994;161:148–152.
   PubMedGoogle Scholar
• Mousavi S, Bereswill S, Heimesaat MM. Murine models for the investigation of colonization resistance and innate immune responses in campylobacter jejuni infections. Curr Top Microbiol Immunol. 2021;431(233–263). doi:10.1007/978-3-030-65481-8_9.
   PubMedGoogle Scholar
• Gradel KO, Nielsen, HL, Schonheyder, HC, Ejlertsen, T, Kristensen, B, Nielsen, H, et al. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology. 2009;137 2 :495–501. doi:10.1053/j.gastro.2009.04.001
   PubMed Web of Science ®Google Scholar
• Peters S, Pascoe, B, Wu, Z, Bayliss, SC, Zeng, X, Edwinson, A, et al. Campylobacter jejuni genotypes are associated with post-infection irritable bowel syndrome in humans. Commun Biol. 2021;4:1015. doi:10.1038/s42003-021-02554-8
   PubMed Web of Science ®Google Scholar
• Mortensen NP, Kuijf, ML, Wim Ang, C, Schiellerup, P, Krogfelt, KA, Jacobs, BC, van Belkum, A, Ph Endtz, H, Bergman, MP, et al. Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastro-enteritis and reactive arthritis. Microbes Infect. 2009;11:12 988–994 . doi:10.1016/j.micinf.2009.07.004
   PubMed Web of Science ®Google Scholar
• Huizinga R, van den Berg, B, van Rijs, W, Tio-Gillen, A, Fokkink, WJR, Bakker-Jonges, LE, Geleijns, Karin, Samsom, JN, van Doorn, PA, Laman, JD, Jacobs, BC, et al. Innate immunity to campylobacter jejuni in guillain-barre syndrome. Ann Neurol. 2015;78(3): 343–354. doi:10.1002/ana.24442
   PubMed Web of Science ®Google Scholar
• Bucker R, Krug, SM, Moos, V, Bojarski, C, Schweiger, MR, Kerick, M, Fromm, A, et al. Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon. Mucosal Immunol. 2018;11(2):474–485. doi:10.1038/mi.2017.66
   PubMed Web of Science ®Google Scholar
• Mousavi S, Bereswill S, Heimesaat MM. Novel clinical campylobacter jejuni infection models based on sensitization of mice to lipooligosaccharide, a major bacterial factor triggering innate immune responses in human campylobacteriosis. Microorganisms. 2020:8. doi:10.3390/microorganisms8040482.
   Web of Science ®Google Scholar
• Chang C, Miller JF. Campylobacter jejuni colonization of mice with limited enteric flora. Infect Immun. 2006;74(5261–5271). doi:10.1128/IAI.01094-05.
   Google Scholar
• Newell DG, Pearson A. The invasion of epithelial cell lines and the intestinal epithelium of infant mice by Campylobacter jejuni/coli. J Diarrhoeal Dis Res. 1984;2:19–26.
   PubMedGoogle Scholar
• Newell DG, McBride H, Dolby JM. Investigations on the role of flagella in the colonization of infant mice with Campylobacter jejuni and attachment of Campylobacter jejuni to human epithelial cell lines. J Hyg (Lond). 1985;95(217–227). doi:10.1017/s0022172400062653.
   PubMedGoogle Scholar
• Newell DG. Monoclonal antibodies directed against the flagella of Campylobacter jejuni: cross-reacting and serotypic specificity and potential use in diagnosis. J Hyg (Lond). 1986;96(377–384). doi:10.1017/s0022172400066134.
   Google Scholar
• Haag LM, Fischer, A, Otto, B, Grundmann, U, Kühl, AA, Goebel, UB, Bereswill, S, Heimesaat, MM , et al. Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses. Eur J Microbiol Immunol (Bp). 2012;2:2–11. doi:10.1556/EuJMI.2.2012.1.2
   PubMedGoogle Scholar
• Haag LM, Fischer, A, Otto, B, Plickert, R, Kühl, AA, Goebel, UB, Bereswill, S, Heimesaat, MM, et al. Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS One. 2012;7 5 :e35988. doi:10.1371/journal.pone.0035988
   PubMed Web of Science ®Google Scholar
• Ferreira RBR, Gill, N, Willing, BP, Antunes, LCM, Russell, SL, Croxen, MA, Finlay, BB, et al. The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization. PLoS One. 2011;6 5 :e20338. doi:10.1371/journal.pone.0020338
   PubMed Web of Science ®Google Scholar
• Russell SL, Gold, MJ, Hartmann, M, Willing, BP, Thorson, L, Wlodarska, M, Gill, N, et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012;13 5 :440–447. doi:10.1038/embor.2012.32
   PubMed Web of Science ®Google Scholar
• Stahl M, Ries, J, Vermeulen, J, Yang, H, Sham, HP, Crowley, SM, Badayeva, Y, et al. A novel mouse model of Campylobacter jejuni gastroenteritis reveals key pro-inflammatory and tissue protective roles for Toll-like receptor signaling during infection. PLoS Pathog. 2014;10 7 :e1004264. doi:10.1371/journal.ppat.1004264
   PubMed Web of Science ®Google Scholar
• Iizumi T, Taniguchi, T, Yamazaki, W, Vilmen, G, Alekseyenko, AV, Gao, Z, Perez, GIP, Blaser, MJ, et al. Effect of antibiotic pre-treatment and pathogen challenge on the intestinal microbiota in mice. Gut Pathog. 2016;8(60). doi:10.1186/s13099-016-0143-z
   PubMedGoogle Scholar
• O’Loughlin JL, Samuelson, DR, Braundmeier-Fleming, AG, White, BA, Haldorson, GJ, Stone, JB, Lessmann, JJ, Eucker, Tyson, et al. The Intestinal microbiota influences campylobacter jejuni colonization and extraintestinal dissemination in mice. Appl Environ Microbiol. 2015;81 14 :4642–4650. doi:10.1128/AEM.00281-15
   PubMed Web of Science ®Google Scholar
• Stahl M, Vallance BA. Insights into Campylobacter jejuni colonization of the mammalian intestinal tract using a novel mouse model of infection. Gut Microbes. 2015;6(143–148). doi:10.1080/19490976.2015.1016691.
   PubMedGoogle Scholar
• Mansfield LS, Bell, JA, Wilson, DL, Murphy, AJ, Elsheikha, HM, Rathinam, VAK, Fierro, BR, Linz, JE, Young, VB, et al. C57BL/6 and congenic interleukin-10-deficient mice can serve as models of Campylobacter jejuni colonization and enteritis. Infect Immun. 2007;75(3): 1099–1115. doi:10.1128/IAI.00833-06
   PubMed Web of Science ®Google Scholar
• Masanta WO, Heimesaat, MM, Bereswill, S, Tareen, AM, Lugert, R, Gross, U, Zautner, AE, et al. Modification of intestinal microbiota and its consequences for innate immune response in the pathogenesis of campylobacteriosis. Clin Dev Immunol. 2013;2013(526860). doi:10.1155/2013/526860
   PubMedGoogle Scholar
• Heimesaat MM, Alutis, M, Grundmann, U, Fischer, A, Tegtmeyer, N, Boehm, M, Kühl, AA, Goebel, UB, Backert, S, Bereswill, S, et al. The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice. Front Cell Infect Microbiol. 2014;4(77). doi:10.3389/fcimb.2014.00077
   PubMedGoogle Scholar
• Heimesaat MM, Bereswill S. Murine infection models for the investigation of Campylobacter jejuni–host interactions and pathogenicity. Berl Munch Tierarztl Wochenschr. 2015;128(3–4):98–103.
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Escher, U, Mousavi, S, Tegtmeyer, N, Boehm, M, Backert, S, Bereswill, S, Heimesaat, MM, et al. Immunopathological properties of the Campylobacter jejuni flagellins and the adhesin CadF as assessed in a clinical murine infection model. Gut Pathog. 2019;11(24). doi:10.1186/s13099-019-0306-9
   PubMedGoogle Scholar
• Debruyne L, Gevers D, Vandamme P in Campylobacter 1-25 (2008).
   Google Scholar
• Tegtmeyer N, Sharafutdinov, I, Harrer, A, Esmaeili, DS, Linz, B, Backert, S, et al. Campylobacter Virulence Factors and Molecular Host-Pathogen Interactions. Curr Top Microbiol Immunol. 2021;431: 169–202. doi:10.1007/978-3-030-65481-8_7
   PubMed Web of Science ®Google Scholar
• Li J, Gulbronson CJ, Bogacz M, Hendrixson DR, Thompson SA. FliW controls growth-phase expression of Campylobacter jejuni flagellar and non-flagellar proteins via the post-transcriptional regulator CsrA. Microbiology (Reading). 2018;164(1308–1319). doi:10.1099/mic.0.000704.
   Google Scholar
• Ren F, Li, X, Tang, H, Jiang, Q, Yun, X, Fang, L, Huang, P, Tang, Y, Li, Q, Huang, J, Jiao, X, et al. Insights into the impact of flhF inactivation on Campylobacter jejuni colonization of chick and mice gut. BMC Microbiol. 2018;18(1):149. doi:10.1186/s12866-018-1318-1
   PubMedGoogle Scholar
• Burnham PM, Hendrixson DR. Campylobacter jejuni: collective components promoting a successful enteric lifestyle. Nat Rev Microbiol. 2018;16(551–565). doi:10.1038/s41579-018-0037-9.
   PubMedGoogle Scholar
• St Michael F, Szymanski, CM, Li, J, Chan, KH, Khieu, NH, Larocque, S, Wakarchuk, WW, Brisson, JR, Monteiro, MA, et al. The structures of the lipooligosaccharide and capsule polysaccharide of Campylobacter jejuni genome sequenced strain NCTC 11168. Eur J Biochem. 2002;269(21):5119–5136. doi:10.1046/j.1432-1033.2002.03201.x
   PubMedGoogle Scholar
• Guerry P, Poly, F, Riddle, M, Maue, AC, Chen, Yu-Han, Monteiro, MA, et al. Campylobacter polysaccharide capsules: virulence and vaccines. Front Cell Infect Microbiol. 2012;2(7). doi:10.3389/fcimb.2012.00007
   PubMedGoogle Scholar
• Rose A, Kay E, Wren BW, Dallman MJ. The Campylobacter jejuni NCTC11168 capsule prevents excessive cytokine production by dendritic cells. Med Microbiol Immunol. 2012;201(137–144). doi:10.1007/s00430-011-0214-1.
   PubMedGoogle Scholar
• Kim S, Vela, A, Clohisey, SM, Athanasiadou, S, Kaiser, P, Stevens, MP, Vervelde, L, et al. Host-specific differences in the response of cultured macrophages to Campylobacter jejuni capsule and O-methyl phosphoramidate mutants. Vet Res. 2018;49(1):3. doi:10.1186/s13567-017-0501-y
   PubMedGoogle Scholar
• Karlyshev AV, Ketley JM, Wren BW. The Campylobacter jejuni glycome. FEMS Microbiol Rev. 2005;29(377–390). doi:10.1016/j.femsre.2005.01.003.
   PubMedGoogle Scholar
• Hameed A, Woodacre A, Machado LR, Marsden GL. An updated classification system and review of the lipooligosaccharide biosynthesis gene locus in campylobacter jejuni. Front Microbiol. 2020;11(677). doi:10.3389/fmicb.2020.00677.
   Google Scholar
• Godschalk PC, Heikema, A. P., Gilbert, M., Komagamine, T. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome. J Clin Invest. 2004;114(1659–1665). doi:10.1172/JCI15707
   PubMedGoogle Scholar
• Heimesaat MM, Lugert, R., Fischer, A., Alutis, M. Impact of Campylobacter jejuni cj0268c knockout mutation on intestinal colonization, translocation, and induction of immunopathology in gnotobiotic IL-10 deficient mice. PLoS One. 2014;9(e90148). doi:10.1371/journal.pone.0090148
   Google Scholar
• Schmidt AM, Escher, U., Mousavi, S., Boehm, M. Protease activity of campylobacter jejuni HtrA modulates distinct intestinal and systemic immune responses in infected secondary abiotic IL-10 deficient mice. Front Cell Infect Microbiol. 2019;9(79). doi:10.3389/fcimb.2019.00079
   PubMedGoogle Scholar
• Lobo de Sá FD, Butkevych, E., Nattramilarasu, P. K. Curcumin mitigates immune-induced epithelial barrier dysfunction by campylobacter jejuni. Int J Mol Sci. 2019;20(4830).
   PubMedGoogle Scholar
• Mousavi S, Lobo de Sá, F. D., Schulzke, J. D., Bücker, R. Vitamin D in Acute campylobacteriosis-results from an intervention study applying a clinical campylobacter jejuni induced enterocolitis model. Front Immunol. 2019;10(2094). doi:10.3389/fimmu.2019.02094
   PubMedGoogle Scholar
• Mousavi S, Escher, U., Thunhorst, E., Kittler, S. Vitamin C alleviates acute enterocolitis in Campylobacter jejuni infected mice. Sci Rep. 2020;10(2921). doi:10.1038/s41598-020-59890-8
   Google Scholar
• Mousavi S, Schmidt, A. M., Escher, U., Kittler, S. Carvacrol ameliorates acute campylobacteriosis in a clinical murine infection model. Gut Pathog. 2020;12(2). doi:10.1186/s13099-019-0343-4
   PubMedGoogle Scholar
• Mousavi S, Weschka D, Bereswill S, Heimesaat MM. Preclinical evaluation of oral urolithin-A for the treatment of acute campylobacteriosis in campylobacter jejuni infected microbiota-depleted IL-10(-/-) Mice. Pathogens. 2020:10. doi:10.3390/pathogens10010007.
   PubMed Web of Science ®Google Scholar
• Bereswill S, Mousavi S, Weschka D, Heimesaat MM. Disease-alleviating effects of peroral activated charcoal treatment in acute murine campylobacteriosis. Microorganisms. 2021:9. doi:10.3390/microorganisms9071424.
   Web of Science ®Google Scholar
• Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev. 1998;11(142–201). doi:10.1128/CMR.11.1.142.
   PubMedGoogle Scholar
• Hartland EL, Leong JM. Enteropathogenic and enterohemorrhagic E. coli: ecology, pathogenesis, and evolution. Front Cell Infect Microbiol. 2013;3:15. doi:10.3389/fcimb.2013.00015.
   PubMed Web of Science ®Google Scholar
• Wales AD, Woodward MJ, Pearson GR. Attaching-effacing bacteria in animals. J Comp Pathol. 2005;132(1–26). doi:10.1016/j.jcpa.2004.09.005.
   Web of Science ®Google Scholar
• Moon HW, Whipp SC, Argenzio RA, Levine MM, Giannella RA. Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect Immun. 1983;41(1340–1351). doi:10.1128/iai.41.3.1340-1351.1983.
   PubMedGoogle Scholar
• Cantey JR, Blake RK. Diarrhea due to Escherichia coli in the rabbit: a novel mechanism. J Infect Dis. 1977;135(454–462). doi:10.1093/infdis/135.3.454.
   PubMedGoogle Scholar
• Garcia A, Bosques, C. J., Wishnok, J. S., Feng, Y. Renal injury is a consistent finding in Dutch Belted rabbits experimentally infected with enterohemorrhagic Escherichia coli. J Infect Dis. 2006;193(1125–1134). doi:10.1086/501364
   Google Scholar
• Sueyoshi M, Nakazawa M. Experimental infection of young chicks with attaching and effacing Escherichia coli. Infect Immun. 1994;62(4066–4071). doi:10.1128/iai.62.9.4066-4071.1994.
   PubMedGoogle Scholar
• Tzipori S, Wachsmuth, I. K., Chapman, C., Birner, R., Brittingham, J., Jackson, C. The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157: h7in gnotobiotic piglets. J Infect Dis. 1986;154(712–716). doi:10.1093/infdis/154.4.712
   PubMedGoogle Scholar
• Gunzer F, Hennig-Pauka, I., Waldmann, K. H., Sandhoff, R. Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli. Am J Clin Pathol. 2002;118(364–375). doi:10.1309/UMW9-D06Q-M94Q-JGH2
   PubMedGoogle Scholar
• Dean-Nystrom EA, Stoffregen WC, Bosworth BT, Moon HW, Pohlenz JF. Early attachment sites for Shiga-toxigenic Escherichia coli O157: h7in experimentally inoculated weaned calves. Appl Environ Microbiol. 2008;74(6378–6384). doi:10.1128/AEM.00636-08.
   PubMedGoogle Scholar
• Mohawk KL, O’Brien AD. Mouse models of Escherichia coli O157: h7infection and Shiga toxin injection. J Biomed Biotechnol. 2011;2011(258185). doi:10.1155/2011/258185.
   PubMedGoogle Scholar
• Savkovic SD, Villanueva J, Turner JR, Matkowskyj KA, Hecht G. Mouse model of enteropathogenic Escherichia coli infection. Infect Immun. 2005;73(1161–1170). doi:10.1128/IAI.73.2.1161-1170.2005.
   PubMedGoogle Scholar
• Dupont A, Sommer, F., Zhang, K., Repnik, U. Age-dependent susceptibility to enteropathogenic Escherichia coli (EPEC) infection in mice. PLoS Pathog. 2016;12(e1005616). doi:10.1371/journal.ppat.1005616
   PubMedGoogle Scholar
• Ledwaba SE, Costa, D. V., Bolick, D. T., Giallourou, N. Enteropathogenic Escherichia coli infection induces diarrhea, intestinal damage, metabolic alterations, and increased intestinal permeability in a murine model. Front Cell Infect Microbiol. 2020;10(595266). doi:10.3389/fcimb.2020.595266
   PubMedGoogle Scholar
• Wadolkowski EA, Burris JA, O’Brien AD. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun. 1990;58(2438–2445). doi:10.1128/iai.58.8.2438-2445.1990.
   Google Scholar
• Shimizu K, Asahara, T., Nomoto, K., Tanaka, R., Hamabata, T., Ozawa, A., & Takeda, Y. Development of a lethal Shiga toxin-producing Escherichia coli-infection mouse model using multiple mitomycin C treatment. Microb Pathog. 2003;35(1–9). doi:10.1016/s0882-4010(03)00065-2
   PubMed Web of Science ®Google Scholar
• Eaton KA, Friedman, D. I., Francis, G. J. Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice. Infect Immun. 2008;76(3054–3063). doi:10.1128/IAI.01626-07
   PubMedGoogle Scholar
• Mohawk KL, Melton-Celsa AR, Zangari T, Carroll EE, O’Brien AD. Pathogenesis of Escherichia coli O157: h7strain 86-24 following oral infection of BALB/c mice with an intact commensal flora. Microb Pathog. 2010;48(131–142). doi:10.1016/j.micpath.2010.01.003.
   PubMedGoogle Scholar
• Mundy R, Girard F, FitzGerald AJ, Frankel G. Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium. FEMS Microbiol Lett. 2006;265:126–132. doi:10.1111/j.1574-6968.2006.00481.x.
   PubMed Web of Science ®Google Scholar
• Mullineaux-Sanders C, Suez J, Elinav E, Frankel G. Sieving through gut models of colonization resistance. Nat Microbiol. 2018;3(132–140). doi:10.1038/s41564-017-0095-1.
   PubMedGoogle Scholar
• Luperchio SA, Schauer DB. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect. 2001;3(333–340). doi:10.1016/s1286-4579(01)01387-9.
   PubMedGoogle Scholar
• Petty NK, Bulgin, R., Crepin, V. F. The Citrobacter rodentium genome sequence reveals convergent evolution with human pathogenic Escherichia coli. J Bacteriol. 2010;192(525–538). doi:10.1128/JB.01144-09
   Google Scholar
• Mullineaux-Sanders C, Sanchez-Garrido, J., Hopkins, E. G. Citrobacter rodentium-host-microbiota interactions: immunity, bioenergetics and metabolism. Nat Rev Microbiol. 2019;17(701–715). doi:10.1038/s41579-019-0252-z
   PubMedGoogle Scholar
• McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci USA. 1995;92(1664–1668). doi:10.1073/pnas.92.5.1664.
   Google Scholar
• McDaniel TK, Kaper JB. A cloned pathogenicity Island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. Mol Microbiol. 1997;23:399–407. doi:10.1046/j.1365-2958.1997.2311591.x.
   PubMed Web of Science ®Google Scholar
• Deng W, Li Y, Vallance BA, Finlay BB. Locus of enterocyte effacement from Citrobacter rodentium: sequence analysis and evidence for horizontal transfer among attaching and effacing pathogens. Infect Immun. 2001;69(6323–6335). doi:10.1128/IAI.69.10.6323-6335.2001.
   Google Scholar
• Frankel G, Phillips, A. D., Novakova, M. Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter rodentium eaeA mutant: induction of an immunoglobulin A response to intimin and EspB. Infect Immun. 1996;64(5315–5325). doi:10.1128/iai.64.12.5315-5325.1996
   PubMedGoogle Scholar
• Higgins LM, Frankel, G., Connerton, I., Gonçalves, N. S. Role of bacterial intimin in colonic hyperplasia and inflammation. Science. 1999;285(588–591). doi:10.1126/science.285.5427.588
   PubMedGoogle Scholar
• Frankel G, Phillips, A. D., Trabulsi, L. R. Intimin and the host cell–is it bound to end in Tir(s)? Trends Microbiol. 2001;9:214–218. doi:10.1016/s0966-842x(01)02016-9.
   PubMed Web of Science ®Google Scholar
• Deng W, Vallance BA, Li Y, Puente JL, Finlay BB. Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice. Mol Microbiol. 2003;48(95–115). doi:10.1046/j.1365-2958.2003.03429.x.
   PubMedGoogle Scholar
• Collins JW, Keeney, K. M., Crepin, V. F., Rathinam, V. A. Citrobacter rodentium: infection, inflammation and the microbiota. Nat Rev Microbiol. 2014;12(612–623). doi:10.1038/nrmicro3315
   Google Scholar
• Silberger DJ, Zindl CL, Weaver CT. Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity. Mucosal Immunol. 2017;10(1108–1117). doi:10.1038/mi.2017.47.
   PubMedGoogle Scholar
• Geiger TL, Abt, M. C., Gasteiger, G. Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens. J Exp Med. 2014;211(1723–1731). doi:10.1084/jem.20140212
   PubMedGoogle Scholar
• Nordlander S, Pott J, Maloy KJ. NLRC4 expression in intestinal epithelial cells mediates protection against an enteric pathogen. Mucosal Immunol. 2014;7(775–785). doi:10.1038/mi.2013.95.
   PubMedGoogle Scholar
• Hopkins EGD, Frankel G. Overview of the effect of citrobacter rodentium infection on host metabolism and the microbiota. Methods Mol Biol. 2021;2291(399–418). doi:10.1007/978-1-0716-1339-9_20.
   PubMedGoogle Scholar
• Vallance BA, Deng W, Jacobson K, Finlay BB. Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect Immun. 2003;71(3443–3453). doi:10.1128/IAI.71.6.3443-3453.2003.
   PubMedGoogle Scholar
• Itoh K, Matsui T, Tsuji K, Mitsuoka T, Ueda K. Genetic control in the susceptibility of germfree inbred mice to infection by Escherichia coli O115a,c:K(B). Infect Immun. 1988;56(930–935). doi:10.1128/iai.56.4.930-935.1988.
   PubMedGoogle Scholar
• Papapietro O, Teatero, S., Thanabalasuriar, A. R-spondin 2 signalling mediates susceptibility to fatal infectious diarrhoea. Nat Commun. 2013;4(1898). doi:10.1038/ncomms2816
   PubMedGoogle Scholar
• Vaahtovuo J, Toivanen P, Eerola E. Bacterial composition of murine fecal microflora is indigenous and genetically guided. FEMS Microbiol Ecol. 2003;44(131–136). doi:10.1016/S0168-6496(02)00460-9.
   PubMedGoogle Scholar
• Ghosh S, Dai, C., Brown, K., Rajendiran, E. Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression. Am J Physiol Gastrointest Liver Physiol. 2011;301(G39–49). doi:10.1152/ajpgi.00509.2010
   PubMedGoogle Scholar
• Willing BP, Vacharaksa A, Croxen M, Thanachayanont T, Finlay BB. Altering host resistance to infections through microbial transplantation. PLoS One. 2011;6(e26988). doi:10.1371/journal.pone.0026988.
   Google Scholar
• Osbelt L, Thiemann, S., Smit, N., Lesker, T. R. Variations in microbiota composition of laboratory mice influence Citrobacter rodentium infection via variable short-chain fatty acid production. PLoS Pathog. 2020;16. e1008448. doi:10.1371/journal.ppat.1008448
   PubMed Web of Science ®Google Scholar
• Chen J, Waddell A, Lin YD, Cantorna MT. Dysbiosis caused by vitamin D receptor deficiency confers colonization resistance to Citrobacter rodentium through modulation of innate lymphoid cells. Mucosal Immunol. 2015;8(618–626). doi:10.1038/mi.2014.94.
   Google Scholar
• Kamada N, Kim, Y. G., Sham, H. P., Vallance, B. A. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science. 2012;336(1325–1329). doi:10.1126/science.1222195
   PubMedGoogle Scholar
• Kamada N, Sakamoto, K., Seo, S. U., Zeng, M. Y. Humoral immunity in the gut selectively targets phenotypically virulent attaching-and-effacing bacteria for intraluminal elimination. Cell Host Microbe. 2015;17(617–627). doi:10.1016/j.chom.2015.04.001
   PubMedGoogle Scholar
• Kim YG, Sakamoto, K., Seo, S. U., Pickard, J. M. Neonatal acquisition of Clostridia species protects against colonization by bacterial pathogens. Science. 2017;356(315–319). doi:10.1126/science.aag2029
   Google Scholar
• Mullineaux-Sanders C, Collins, J. W., Ruano-Gallego, D., Levy, M. Citrobacter rodentium Relies on commensals for colonization of the colonic mucosa. Cell Rep. 2017;21(3381–3389). doi:10.1016/j.celrep.2017.11.086
   PubMedGoogle Scholar
• Herp S, Brugiroux, S., Garzetti, D., Ring, D. Mucispirillum schaedleri Antagonizes Salmonella Virulence to Protect Mice against Colitis. Cell Host Microbe. 2019;25:681–694. doi:10.1016/j.chom.2019.03.004.
   PubMed Web of Science ®Google Scholar
• Buschor S, Cuenca, M., Uster, S. S., Schären, O. P. Innate immunity restricts Citrobacter rodentium A/E pathogenesis initiation to an early window of opportunity. PLoS Pathog. 2017;13(e1006476). doi:10.1371/journal.ppat.1006476
   PubMedGoogle Scholar
• Maattanen P, Lurz, E., Botts, S. R., Wu, R. Y., Yeung, C. W., Li, B. & Sherman, P. M. Ground flaxseed reverses protection of a reduced-fat diet against Citrobacter rodentium-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2018;315:G788–G798. doi:10.1152/ajpgi.00101.2018.
   PubMed Web of Science ®Google Scholar
• Collins JW, Chervaux, C., Raymond, B., Derrien, M. Fermented dairy products modulate Citrobacter rodentium-induced colonic hyperplasia. J Infect Dis. 2014;210(1029–1041). doi:10.1093/infdis/jiu205
   Google Scholar
• Desai MS, Seekatz, A. M., Koropatkin, N. M., Kamada, N. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016;167:1339–1353. doi:10.1016/j.cell.2016.10.043.
   PubMed Web of Science ®Google Scholar
• Zenewicz LA, Yin, X., Wang, G., Elinav, E. IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J Immunol. 2013;190:5306–5312. doi:10.4049/jimmunol.1300016.
   PubMed Web of Science ®Google Scholar
• Varcoe JJ, Krejcarek G, Busta F, Brady L. Prophylactic feeding of Lactobacillus acidophilus NCFM to mice attenuates overt colonic hyperplasia. J Food Prot. 2003;66(457–465). doi:10.4315/0362-028x-66.3.457.
   PubMedGoogle Scholar
• Johnson-Henry KC, Nadjafi, M., Avitzur, Y., Mitchell, D. J. Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J Infect Dis. 2005;191(2106–2117). doi:10.1086/430318
   PubMedGoogle Scholar
• Chen CC, Chiu CH, Lin TY, Shi HN, Walker WA. Effect of probiotics Lactobacillus acidophilus on Citrobacter rodentium colitis: the role of dendritic cells. Pediatr Res. 2009;65(169–175). doi:10.1203/PDR.0b013e31818d5a06.
   Google Scholar
• Gareau MG, Wine E, Reardon C, Sherman PM. Probiotics prevent death caused by Citrobacter rodentium infection in neonatal mice. J Infect Dis. 2010;201(81–91). doi:10.1086/648614.
   PubMedGoogle Scholar
• Rodrigues DM, Sousa AJ, Johnson-Henry KC, Sherman PM, Gareau MG. Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. J Infect Dis. 2012;206(99–109). doi:10.1093/infdis/jis177.
   PubMedGoogle Scholar
• Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut. 2003;52(827–833). doi:10.1136/gut.52.6.827.
   PubMedGoogle Scholar
• Collins JW, Akin, A. R., Kosta, A., Zhang, N., Tangney, M., Francis, K. P., & Frankel, G. Pre-treatment with Bifidobacterium breve UCC2003 modulates Citrobacter rodentium-induced colonic inflammation and organ specificity. Microbiology (Reading). 2012;158(2826–2834). doi:10.1099/mic.0.060830-0
   PubMedGoogle Scholar
• Fanning S, Hall, L. J., Cronin, M., Zomer, A., MacSharry, J., Goulding, D. & van Sinderen, D. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci USA. 2012;109(2108–2113). doi:10.1073/pnas.1115621109
   Google Scholar
• Ivanov II, Atarashi, K., Manel, N., Brodie, E. L. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(485–498). doi:10.1016/j.cell.2009.09.033
   PubMedGoogle Scholar
• Woo V, Eshleman, E. M., Hashimoto-Hill, S., Whitt, J. Commensal segmented filamentous bacteria-derived retinoic acid primes host defense to intestinal infection. Cell Host Microbe. 2021;29:1744–1756. doi:10.1016/j.chom.2021.09.010.
   PubMed Web of Science ®Google Scholar
• Mullineaux-Sanders C, Carson, D., Hopkins, E. G., Glegola-Madejska, I. Citrobacter amalonaticus inhibits the growth of citrobacter rodentium in the gut lumen. mBio. 2021;12(e0241021). doi:10.1128/mBio.02410-21
   PubMedGoogle Scholar
• Wu X, Vallance, B. A., Boyer, L., Bergstrom, K. S. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol. 2008;294(G295–306). doi:10.1152/ajpgi.00173.2007
   Google Scholar
• Curtis MM, Hu, Z., Klimko, C., Narayanan, S. The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape. Cell Host Microbe. 2014;16(759–769). doi:10.1016/j.chom.2014.11.005
   PubMedGoogle Scholar
• Bergstrom KS, Kissoon-Singh, V., Gibson, D. L., Ma, C. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog. 2010;6(e1000902). doi:10.1371/journal.ppat.1000902
   PubMedGoogle Scholar
• Lawson PA, Citron DM, Tyrrell KL, Finegold SM. Reclassification of clostridium difficile as clostridioides difficile (Hall and O’Toole 1935) Prevot 1938. Anaerobe. 2016;40(95–99). doi:10.1016/j.anaerobe.2016.06.008.
   PubMedGoogle Scholar
• Bauer MP, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377(63–73). doi:10.1016/S0140-6736(10)61266-4
   PubMedGoogle Scholar
• Guh AY, Mu, Y., Winston, L. G., Johnston, H. Trends in U.S. Burden of clostridioides difficile infection and outcomes. N Engl J Med. 2020;382:1320–1330. doi:10.1056/NEJMoa1910215.
   PubMed Web of Science ®Google Scholar
• Kampouri E, Croxatto A, Prod’hom G, Guery B. Clostridioides difficile infection, still a long way to go. J Clin Med. 2021:10. doi:10.3390/jcm10030389.
   PubMed Web of Science ®Google Scholar
• Reigadas Ramirez E, Bouza ES. Economic burden of clostridium difficile infection in European Countries. Adv Exp Med Biol. 2018;1050(1–12). doi:10.1007/978-3-319-72799-8_1.
   PubMedGoogle Scholar
• Fu Y, Luo Y, Grinspan AM. Epidemiology of community-acquired and recurrent Clostridioides difficile infection. Therap Adv Gastroenterol. 2021;14(17562848211016248). doi:10.1177/17562848211016248.
   PubMedGoogle Scholar
• Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. 207 (European Centre for Disease Prevention and Control, Stockholm, 2013).
   Google Scholar
• Lessa FC, Mu, Y., Bamberg, W. M., Beldavs, Z. G. Burden of clostridium difficile infection in the United States. N Engl J Med. 2015;372(825–834). doi:10.1056/NEJMoa1408913
   Google Scholar
• Penit A, Bemer, P., Besson, J., Cazet, L. Community-acquired Clostridium difficile infections. Med Mal Infect. 2016;46(131–139). doi:10.1016/j.medmal.2016.01.007
   PubMedGoogle Scholar
• Warriner K, Xu C, Habash M, Sultan S, Weese SJ. Dissemination of Clostridium difficile in food and the environment: significant sources of C. difficile community-acquired infection? J Appl Microbiol. 2017;122:542–553. doi:10.1111/jam.13338.
   PubMed Web of Science ®Google Scholar
• Czepiel J, Dróżdż, M., Pituch, H., Kuijper, E. J. Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis. 2019;38(1211–1221). doi:10.1007/s10096-019-03539-6
   PubMedGoogle Scholar
• Crobach MJT, Vernon, J. J., Loo, V. G., Kong, L. Y. Understanding clostridium difficile colonization. Clin Microbiol Rev. 2018;31. doi:10.1128/CMR.00021-17.
   PubMed Web of Science ®Google Scholar
• Smits WK, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ. Clostridium difficile infection. Nat Rev Dis Primers. 2016;2:16020. doi:10.1038/nrdp.2016.20.
   PubMed Web of Science ®Google Scholar
• Zacharioudakis IM, Zervou FN, Pliakos EE, Ziakas PD, Mylonakis E. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:381–390. doi:10.1038/ajg.2015.22.
   PubMed Web of Science ®Google Scholar
• Kuehne SA, Cartman, S. T., Heap, J. T., Kelly, M. L. The role of toxin A and toxin B in Clostridium difficile infection. Nature. 2010;467(711–713). doi:10.1038/nature09397
   PubMedGoogle Scholar
• Chandrasekaran R, Lacy DB. The role of toxins in Clostridium difficile infection. FEMS Microbiol Rev. 2017;41(723–750). doi:10.1093/femsre/fux048.
   PubMedGoogle Scholar
• Louie TJ, Miller, M. A., Mullane, K. M., Weiss, K., Lentnek, A., Golan, Y. & Shue, Y. K. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(422–431). doi:10.1056/NEJMoa0910812
   PubMedGoogle Scholar
• Johnson S, Louie, T. J., Gerding, D. N., Cornely, O. A., Chasan-Taber, S., Fitts, D. & Polymer Alternative for CDI Treatment (PACT) investigators. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis. 2014;59(345–354). doi:10.1093/cid/ciu313
   Google Scholar
• Oksi J, Anttila VJ, Mattila E. Treatment of Clostridioides (Clostridium) difficile infection. Ann Med. 2020;52(12–20). doi:10.1080/07853890.2019.1701703.
   PubMedGoogle Scholar
• Lee C, Louie, T. J., Weiss, K., Valiquette, L., Gerson, M., Arnott, W., & Gorbach, S. L. Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes. Can J Infect Dis Med Microbiol. 2016;2016(8048757). doi:10.1155/2016/8048757
   PubMedGoogle Scholar
• van Prehn J, Reigadas, E., Vogelzang, E. H., Bouza, E., Hristea, A., Guery, B. & Kuijper, E. J. European society of clinical microbiology and infectious diseases: 2021 update on the treatment guidance document for clostridioides difficile infection in adults. Clin Microbiol Infect. 2021;27(Suppl 2):S1–S21. doi:10.1016/j.cmi.2021.09.038.
   PubMedGoogle Scholar
• Fekety R, Silva, J., Toshniwal, R., Allo, M., Armstrong, J., Browne, R. & Rifkin, G. Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters. Rev Infect Dis. 1979;1(386–397). doi:10.1093/clinids/1.2.386
   PubMedGoogle Scholar
• Knoop FC. Clindamycin-associated enterocolitis in Guinea pigs: evidence for a bacterial toxin. Infect Immun. 1979;23(31–33). doi:10.1128/iai.23.1.31-33.1979.
   PubMedGoogle Scholar
• Onderdonk AB, Cisneros RL, Bartlett JG. Clostridium difficile in gnotobiotic mice. Infect Immun. 1980;28(277–282). doi:10.1128/iai.28.1.277-282.1980.
   PubMedGoogle Scholar
• Czuprynski CJ, Johnson WJ, Balish E, Wilkins T. Pseudomembranous colitis in Clostridium difficile-monoassociated rats. Infect Immun. 1983;39(1368–1376). doi:10.1128/iai.39.3.1368-1376.1983.
   PubMedGoogle Scholar
• Chen X, Katchar, K., Goldsmith, J. D., Nanthakumar, N., Cheknis, A., Gerding, D. N., & Kelly, C. P. A mouse model of Clostridium difficile-associated disease. Gastroenterology. 2008;135(1984–1992). doi:10.1053/j.gastro.2008.09.002
   Google Scholar
• Castro-Cordova P, Diaz-Yanez F, Munoz-Miralles J, Gil F, Paredes-Sabja D. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence. Anaerobe. 2020;62(102149). doi:10.1016/j.anaerobe.2020.102149.
   PubMedGoogle Scholar
• Winston JA, Thanissery R, Montgomery SA, Theriot CM. Cefoperazone-treated mouse model of clinically-relevant clostridium difficile strain R20291. J Vis Exp. 2016. doi:10.3791/54850.
   PubMed Web of Science ®Google Scholar
• Studer N, Desharnais, L., Beutler, M., Brugiroux, S., Terrazos, M. A., Menin, L. & Hapfelmeier, S. Functional intestinal bile acid 7alpha-dehydroxylation by clostridium scindens associated with protection from clostridium difficile infection in a gnotobiotic mouse model. Front Cell Infect Microbiol. 2016;6(191). doi:10.3389/fcimb.2016.00191
   PubMedGoogle Scholar
• Yamaguchi T, Konishi, H., Aoki, K., Ishii, Y., Chono, K., & Tateda, K. The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin. J Infect Chemother. 2020;26(483–491). doi:10.1016/j.jiac.2019.12.020
   Google Scholar
• Lai YH, Tsai, B. Y., Hsu, C. Y., Chen, Y. H., Chou, P. H., Chen, Y. L. & Hung, Y. P. The role of toll-like receptor-2 in clostridioides difficile infection: evidence from a mouse model and clinical patients. Front Immunol. 2021;12(691039). doi:10.3389/fimmu.2021.691039
   Google Scholar
• Pruss KM, Sonnenburg JL. C. difficile exploits a host metabolite produced during toxin-mediated disease. Nature. 2021;593:261–265. doi:10.1038/s41586-021-03502-6.
   PubMed Web of Science ®Google Scholar
• Deakin LJ, Clare, S., Fagan, R. P., Dawson, L. F., Pickard, D. J., West, M. R. & Lawley, T. D. The Clostridium difficile spo0A gene is a persistence and transmission factor. Infect Immun. 2012;80(2704–2711). doi:10.1128/IAI.00147-12
   PubMedGoogle Scholar
• Jenior ML, Leslie JL, Young VB, Schloss PD. Clostridium difficile colonizes alternative nutrient niches during infection across distinct murine gut microbiomes. mSystems. 2017:2. doi:10.1128/mSystems.00063-17.
   PubMed Web of Science ®Google Scholar
• Jenior ML, Leslie JL, Young VB, Schloss PD. Clostridium difficile Alters the structure and metabolism of distinct cecal microbiomes during initial infection to promote sustained colonization. mSphere. 2018:3. doi:10.1128/mSphere.00261-18.
   PubMed Web of Science ®Google Scholar
• Koenigsknecht MJ, Theriot, C. M., Bergin, I. L., Schumacher, C. A., Schloss, P. D., & Young, V. B. Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract. Infect Immun. 2015;83(934–941). doi:10.1128/IAI.02768-14
   PubMedGoogle Scholar
• Corthier G, Muller MC, Elmer GW, Lucas F, Dubos-Ramare F. Interrelationships between digestive proteolytic activities and production and quantitation of toxins in pseudomembranous colitis induced by Clostridium difficile in gnotobiotic mice. Infect Immun. 1989;57(3922–3927). doi:10.1128/iai.57.12.3922-3927.1989.
   Google Scholar
• Aguirre AM, Yalcinkaya, N., Wu, Q., Swennes, A., Tessier, M. E., Roberts, P. & Sorg, J. A. Bile acid-independent protection against Clostridioides difficile infection. PLoS Pathog. 2021;17(e1010015). doi:10.1371/journal.ppat.1010015
   PubMedGoogle Scholar
• Girinathan BP, DiBenedetto, N., Worley, J. N., Peltier, J., Arrieta-Ortiz, M. L., Immanuel, S. R. C. & Bry, L. In vivo commensal control of Clostridioides difficile virulence. Cell Host Microbe. 2021;29:1693–1708. doi:10.1016/j.chom.2021.09.007.
   PubMed Web of Science ®Google Scholar
• Corthier G, Muller MC, Wilkins TD, Lyerly D, L’Haridon R. Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A. Infect Immun. 1991;59(1192–1195). doi:10.1128/iai.59.3.1192-1195.1991.
   PubMedGoogle Scholar
• Bouillaut L, Self WT, Sonenshein AL. Proline-dependent regulation of Clostridium difficile Stickland metabolism. J Bacteriol. 2013;195(844–854). doi:10.1128/JB.01492-12.
   Google Scholar
• Lopez CA, McNeely TP, Nurmakova K, Beavers WN, Skaar EP. Clostridioides difficile proline fermentation in response to commensal clostridia. Anaerobe. 2020;63(102210). doi:10.1016/j.anaerobe.2020.102210.
   PubMedGoogle Scholar
• Ng KM, Ferreyra, J. A., Higginbottom, S. K., Lynch, J. B., Kashyap, P. C., Gopinath, S. & Sonnenburg, J. L. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature. 2013;502:96–99. doi:10.1038/nature12503.
   PubMed Web of Science ®Google Scholar
• Buffie CG, Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A. & Pamer, E. G. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015;517(205–208). doi:10.1038/nature13828
   PubMedGoogle Scholar
• Kang JD, Myers, C. J., Harris, S. C., Kakiyama, G., Lee, I. K., Yun, B. S. & Hylemon, P. B. Bile acid 7alpha-dehydroxylating gut bacteria secrete antibiotics that inhibit clostridium difficile: role of secondary bile acids. Cell Chem Biol. 2019;26:27–34. doi:10.1016/j.chembiol.2018.10.003.
   PubMed Web of Science ®Google Scholar
• Jukes CA, Ijaz, U. Z., Buckley, A., Spencer, J., Irvine, J., Candlish, D. & Douce, G. Bile salt metabolism is not the only factor contributing to Clostridioides (Clostridium) difficile disease severity in the murine model of disease. Gut Microbes. 2020;11(481–496). doi:10.1080/19490976.2019.1678996
   PubMedGoogle Scholar
• Seekatz AM, Theriot, C. M., Molloy, C. T., Wozniak, K. L., Bergin, I. L., & Young, V. B. Fecal microbiota transplantation eliminates clostridium difficile in a murine model of relapsing disease. Infect Immun. 2015;83(3838–3846). doi:10.1128/IAI.00459-15
   PubMedGoogle Scholar
• Mullish BH, McDonald, J. A., Pechlivanis, A., Allegretti, J. R., Kao, D., Barker, G. F. & Marchesi, J. R. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection. Gut. 2019;68(1791–1800). doi:10.1136/gutjnl-2018-317842
   Google Scholar
• Li X, Kang, Y., Huang, Y., Xiao, Y., Song, L., Lu, S., & Ren, Z. A strain of Bacteroides thetaiotaomicron attenuates colonization of Clostridioides difficile and affects intestinal microbiota and bile acids profile in a mouse model. Biomed Pharmacother. 2021;137(111290). doi:10.1016/j.biopha.2021.111290
   Google Scholar
• Hryckowian AJ, Van Treuren, W., Smits, S. A., Davis, N. M., Gardner, J. O., Bouley, D. M., & Sonnenburg, J. L. Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model. Nat Microbiol. 2018;3(662–669). doi:10.1038/s41564-018-0150-6
   PubMedGoogle Scholar
• Zhang W, Zou, G., Li, B., Du, X., Sun, Z., Sun, Y., & Jiang, X. Fecal microbiota transplantation (FMT) alleviates experimental colitis in mice by gut microbiota regulation. J Microbiol Biotechnol. 2020;30(1132–1141). doi:10.4014/jmb.2002.02044
   Google Scholar
• Varga A, Kocsis, B., Sipos, D., Kása, P., Vigvári, S., Pál, S. & Péterfi, Z. How to apply FMT more effectively, conveniently and flexible - a comparison of FMT methods. Front Cell Infect Microbiol. 2021;11(657320). doi:10.3389/fcimb.2021.657320
   Google Scholar
• (USA), F. a. D. A. REBYOTA, https://www.fda.gov/vaccines-blood-biologics/vaccines/rebyota (2022).
   Google Scholar
• Khoruts A, Staley C, Sadowsky MJ. Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology. Nat Rev Gastroenterol Hepatol. 2021;18(67–80). doi:10.1038/s41575-020-0350-4.
   PubMedGoogle Scholar
• Nooij S, Ducarmon, Q. R., Laros, J. F., Zwittink, R. D., Norman, J. M., Smits, W. K. & Kuijper, E. J. Fecal microbiota transplantation influences procarcinogenic Escherichia coli in Recipient recurrent clostridioides difficile patients. Gastroenterology. 2021;161:1218–1228. doi:10.1053/j.gastro.2021.06.009.
   PubMed Web of Science ®Google Scholar
• Brandt LJ, Aroniadis, O. C., Mellow, M., Kanatzar, A., Kelly, C., Park, T. & Surawicz, C. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107(1079–1087). doi:10.1038/ajg.2012.60
   PubMedGoogle Scholar
• van Beurden YH, de Groot, P. F., van Nood, E., Nieuwdorp, M., Keller, J. J., & Goorhuis, A. Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection. United European Gastroenterol J. 2017;5(868–879). doi:10.1177/2050640616678099
   PubMedGoogle Scholar
• Jalanka J, Hillamaa, R. Satokari, E. Mattila, V‐J. Anttila, and P. Arkkila. The long-term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2018;47(371–379). doi:10.1111/apt.14443
   Google Scholar
• Petrof EO, Gloor, G. B., Vanner, S. J., Weese, S. J., Carter, D., Daigneault, M. C. & Allen-Vercoe, E. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut. Microbiome. 2013;1(3). doi:10.1186/2049-2618-1-3
   PubMedGoogle Scholar
• Lawley TD, Clare, S., Walker, A. W., Stares, M. D., Connor, T. R., Raisen, C. & Dougan, G. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 2012;8(e1002995). doi:10.1371/journal.ppat.1002995
   PubMedGoogle Scholar
• Pereira FC, Wasmund, K., Cobankovic, I., Jehmlich, N., Herbold, C. W., Lee, K. S. & Berry, D. Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization. Nat Commun. 2020;11(5104). doi:10.1038/s41467-020-18928-1
   Google Scholar
• Nightingale KK, Schukken, Y. H., Nightingale, C. R., Fortes, E. D., Ho, A. J., Her, Z. & Wiedmann, M. Ecology and transmission of Listeria monocytogenes infecting ruminants and in the farm environment. Appl Environ Microbiol. 2004;70(4458–4467). doi:10.1128/AEM.70.8.4458-4467.2004
   PubMedGoogle Scholar
• Bucur FI, Grigore-Gurgu L, Crauwels P, Riedel CU, Nicolau AI. Resistance of Listeria monocytogenes to stress conditions encountered in food and food processing environments. Front Microbiol. 2018;9(2700). doi:10.3389/fmicb.2018.02700.
   PubMedGoogle Scholar
• Silk BJ, Date, K. A., Jackson, K. A., Pouillot, R., Holt, K. G., Graves, L. M. & Mahon, B. E. Invasive listeriosis in the foodborne diseases active surveillance network (FoodNet), 2004-2009: further targeted prevention needed for higher-risk groups. Clin Infect Dis. 2012;54(Suppl 5):S396–404. doi:10.1093/cid/cis268.
   PubMed Web of Science ®Google Scholar
• Churchill KJ, Sargeant JM, Farber JM, O’Connor AM. Prevalence of listeria monocytogenes in select ready-to-eat foods-deli meat, soft cheese, and packaged salad: a systematic review and meta-analysis. J Food Prot. 2019;82(344–357). doi:10.4315/0362-028X.JFP-18-158.
   PubMedGoogle Scholar
• Swaminathan B, Gerner-Smidt P. The epidemiology of human listeriosis. Microbes Infect. 2007;9(1236–1243). doi:10.1016/j.micinf.2007.05.011.
   PubMedGoogle Scholar
• Maury MM, Tsai, Y. H., Charlier, C., Touchon, M., Chenal-Francisque, V., Leclercq, A. & Lecuit, M. Uncovering Listeria monocytogenes hypervirulence by harnessing its biodiversity. Nat Genet. 2016;48(308–313). doi:10.1038/ng.3501
   PubMedGoogle Scholar
• Radoshevich L, Cossart P. Listeria monocytogenes: towards a complete picture of its physiology and pathogenesis. Nat Rev Microbiol. 2018;16(32–46). doi:10.1038/nrmicro.2017.126.
   PubMedGoogle Scholar
• Nikitas G, Deschamps, C., Disson, O., Niault, T., Cossart, P., & Lecuit, M. Transcytosis of Listeria monocytogenes across the intestinal barrier upon specific targeting of goblet cell accessible E-cadherin. J Exp Med. 2011;208(2263–2277). doi:10.1084/jem.20110560
   PubMedGoogle Scholar
• Sheehan B, Klarsfeld A, Msadek T, Cossart P. Differential activation of virulence gene expression by PrfA, the Listeria monocytogenes virulence regulator. J Bacteriol. 1995;177(6469–6476). doi:10.1128/jb.177.22.6469-6476.1995.
   PubMedGoogle Scholar
• Ollinger J, Bowen B, Wiedmann M, Boor KJ, Bergholz TM. Listeria monocytogenes sigmaB modulates PrfA-mediated virulence factor expression. Infect Immun. 2009;77(2113–2124). doi:10.1128/IAI.01205-08.
   PubMedGoogle Scholar
• Gahan CG, Hill C. Listeria monocytogenes: survival and adaptation in the gastrointestinal tract. Front Cell Infect Microbiol. 2014;4(9). doi:10.3389/fcimb.2014.00009.
   PubMedGoogle Scholar
• Sauer JD, Herskovits AA, O’Riordan MXD. Metabolism of the gram-positive bacterial pathogen listeria monocytogenes. Microbiol Spectr. 2019:7. doi:10.1128/microbiolspec.GPP3-0066-2019.
   PubMed Web of Science ®Google Scholar
• Joseph B, Mertins, S., Stoll, R., Schar, J., Umesha, K. R., Luo, Q. & Goebel, W. Glycerol metabolism and PrfA activity in Listeria monocytogenes. J Bacteriol. 2008;190(5412–5430). doi:10.1128/JB.00259-08
   PubMedGoogle Scholar
• Tiensuu T, Guerreiro DN, Oliveira AH, O’Byrne C, Johansson J. Flick of a switch: regulatory mechanisms allowing Listeria monocytogenes to transition from a saprophyte to a killer. Microbiology (Reading). 2019;165(819–833). doi:10.1099/mic.0.000808.
   PubMedGoogle Scholar
• Czuprynski CJ, Balish E. Pathogenesis of Listeria monocytogenes for gnotobiotic rats. Infect Immun. 1981;32(323–331). doi:10.1128/iai.32.1.323-331.1981.
   PubMedGoogle Scholar
• Bambirra FH, Lima, K. G. C., Franco, B. D. G. D. M., Cara, D. C., Nardi, R. M. D., Barbosa, F. H. F., & Nicoli, J. R. Protective effect of Lactobacillus sakei 2a against experimental challenge with Listeria monocytogenes in gnotobiotic mice. Lett Appl Microbiol. 2007;45(663–667). doi:10.1111/j.1472-765X.2007.02250.x
   PubMedGoogle Scholar
• Archambaud C, Nahori, M. A., Soubigou, G., Bécavin, C., Laval, L., Lechat, P., & Cossart, P. Impact of lactobacilli on orally acquired listeriosis. Proc Natl Acad Sci U S A. 2012;109:16684–16689. doi:10.1073/pnas.1212809109.
   PubMed Web of Science ®Google Scholar
• Corr SC, Hill C, Gahan CG. Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens. Adv Food Nutr Res. 2009;56(1–15). doi:10.1016/S1043-4526(08)00601-3.
   PubMedGoogle Scholar
• Brandl K, Plitas G, Schnabl B, DeMatteo RP, Pamer EG. MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J Exp Med. 2007;204(1891–1900). doi:10.1084/jem.20070563.
   PubMedGoogle Scholar
• Las Heras V, Clooney, A. G., Ryan, F. J., Cabrera-Rubio, R., Casey, P. G., Hueston, C. M. & Gahan, C. G. Short-term consumption of a high-fat diet increases host susceptibility to Listeria monocytogenes infection. Microbiome. 2019;7(7). doi:10.1186/s40168-019-0621-x
   PubMedGoogle Scholar
• van Ampting MT, Loonen, L. M., Schonewille, A. J., Konings, I., Vink, C., Iovanna, J. & Bovee-Oudenhoven, I. M. Intestinally secreted C-type lectin Reg3b attenuates salmonellosis but not listeriosis in mice. Infect Immun. 2012;80(1115–1120). doi:10.1128/IAI.06165-11
   PubMedGoogle Scholar
• Rolhion N, Chassaing, B., Nahori, M. A., De Bodt, J., Moura, A., Lecuit, M. & Cossart, P. A listeria monocytogenes bacteriocin can target the commensal prevotella copri and modulate intestinal infection. Cell Host Microbe. 2019;26:691–701. doi:10.1016/j.chom.2019.10.016.
   PubMed Web of Science ®Google Scholar
• Cotter PD, Draper, L. A., Lawton, E. M., Daly, K. M., Groeger, D. S., Casey, P. G. & Hill, C. Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenes. PLoS Pathog. 2008;4(e1000144). doi:10.1371/journal.ppat.1000144
   PubMedGoogle Scholar
• Quereda JJ, Meza-Torres J, Cossart P, Listeriolysin P-CJ. S: a bacteriocin from epidemic Listeria monocytogenes strains that targets the gut microbiota. Gut Microbes. 2017;8(384–391). doi:10.1080/19490976.2017.1290759.
   PubMedGoogle Scholar
• Quereda JJ, Dussurget, O., Nahori, M. A., Ghozlane, A., Volant, S., Dillies, M. A. & Pizarro-Cerda, J. Bacteriocin from epidemic Listeria strains alters the host intestinal microbiota to favor infection. Proc Natl Acad Sci U S A. 2016;113(5706–5711). doi:10.1073/pnas.1523899113
   PubMedGoogle Scholar
• Becattini S, Littmann, E. R., Carter, R. A., Kim, S. G., Morjaria, S. M., Ling, L. & Pamer, E. G. Commensal microbes provide first line defense against Listeria monocytogenes infection. J Exp Med. 2017;214(1973–1989). doi:10.1084/jem.20170495
   PubMedGoogle Scholar
• Corr SC, Gahan CG, Hill C. Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response. FEMS Immunol Med Microbiol. 2007;50(380–388). doi:10.1111/j.1574-695X.2007.00264.x.
   PubMedGoogle Scholar
• Mathipa MG, Bhunia AK, Thantsha MS. Internalin AB-expressing recombinant Lactobacillus casei protects Caco-2 cells from Listeria monocytogenes-induced damages under simulated intestinal conditions. PLoS One. 2019;14(e0220321). doi:10.1371/journal.pone.0220321.
   PubMedGoogle Scholar
• Drolia R, Amalaradjou, M. A. R., Ryan, V., Tenguria, S., Liu, D., Bai, X. & Bhunia, A. K. Receptor-targeted engineered probiotics mitigate lethal Listeria infection. Nat Commun. 2020;11(6344). doi:10.1038/s41467-020-20200-5
   PubMedGoogle Scholar
• Bou Ghanem EN, Jones, G. S., Myers-Morales, T., Patil, P. D., Hidayatullah, A. N., & D'Orazio, S. E. InlA promotes dissemination of Listeria monocytogenes to the mesenteric lymph nodes during food borne infection of mice. PLoS Pathog. 2012;8(e1003015). doi:10.1371/journal.ppat.1003015
   PubMedGoogle Scholar
• Hoelzer K, Pouillot R, Dennis S. Animal models of listeriosis: a comparative review of the current state of the art and lessons learned. Vet Res. 2012;43(18). doi:10.1186/1297-9716-43-18.
   PubMedGoogle Scholar
• Lecuit M, Vandormael-Pournin, S., Lefort, J., Huerre, M., Gounon, P., Dupuy, C. & Cossart, P. A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science. 2001;292(1722–1725). doi:10.1126/science.1059852
   PubMedGoogle Scholar
• Disson O, Grayo, S., Huillet, E., Nikitas, G., Langa-Vives, F., Dussurget, O. & Lecuit, M. Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis. Nature. 2008;455(1114–1118). doi:10.1038/nature07303
   PubMedGoogle Scholar
• Schubert WD, Urbanke, C., Ziehm, T., Beier, V., Machner, M. P., Domann, E. & Heinz, D. W. Structure of internalin, a major invasion protein of Listeria monocytogenes, in complex with its human receptor E-cadherin. Cell. 2002;111(825–836). doi:10.1016/s0092-8674(02)01136-4
   PubMedGoogle Scholar
• Monk IR, Casey PG, Hill C, Gahan CG. Directed evolution and targeted mutagenesis to murinize Listeria monocytogenes internalin A for enhanced infectivity in the murine oral infection model. BMC Microbiol. 2010;10(318). doi:10.1186/1471-2180-10-318.
   PubMedGoogle Scholar
• Tsai YH, Disson O, Bierne H, Lecuit M. Murinization of internalin extends its receptor repertoire, altering Listeria monocytogenes cell tropism and host responses. PLoS Pathog. 2013;9(e1003381). doi:10.1371/journal.ppat.1003381.
   Google Scholar
• Cossart P. Molecular and cellular basis of the infection by Listeria monocytogenes: an overview. International Journal of Medical Microbiology. 2001;291(401–409). doi:10.1078/1438-4221-00146.
   Google Scholar
• Roldgaard BB, Andersen JB, Hansen TB, Christensen BB, Licht TR. Comparison of three Listeria monocytogenes strains in a Guinea-pig model simulating food-borne exposure. FEMS Microbiol Lett. 2009;291(88–94). doi:10.1111/j.1574-6968.2008.01439.x.
   PubMedGoogle Scholar
• Pitts MG, D’Orazio SEF. A comparison of oral and intravenous mouse models of listeriosis. Pathogens. 2018:7. doi:10.3390/pathogens7010013.
   PubMed Web of Science ®Google Scholar
• Holch A, Ingmer H, Licht TR, Gram L. Listeria monocytogenes strains encoding premature stop codons in inlA invade mice and Guinea pig fetuses in orally dosed dams. J Med Microbiol. 2013;62(1799–1806). doi:10.1099/jmm.0.057505-0.
   PubMedGoogle Scholar
• Alam MS, Costales, M., Cavanaugh, C., Pereira, M., Gaines, D., & Williams, K. Oral exposure to Listeria monocytogenes in aged IL-17RKO mice: a possible murine model to study listeriosis in susceptible populations. Microb Pathog. 2016;99(236–246). doi:10.1016/j.micpath.2016.08.035
   PubMedGoogle Scholar
• Mitchell PS, Roncaioli, J. L., Turcotte, E. A., Goers, L., Chavez, R. A., Lee, A. Y. & Vance, R. E. NAIP–NLRC4-deficient mice are susceptible to shigellosis. eLife. 2020;9(e59022). doi:10.7554/eLife.59022
   Google Scholar
• Martz SL, McDonald, J. A., Sun, J., Zhang, Y. G., Gloor, G. B., Noordhof, C. & Petrof, E. O. Administration of defined microbiota is protective in a murine Salmonella infection model. Sci Rep. 2015;5(16094). doi:10.1038/srep16094
   Google Scholar